Research Article
[Retracted] Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis
Table 1
Baseline characteristics of the study population before matching.
| | H101-TACE
() | c-TACE
() | |
| | Age (years), | | | 0.172 | | Gender, (%) | | | 0.108 | | Male | 34 (91.9) | 58 (78.4) | | Female | 3 (8.1) | 16 (21.6) | | HBV, (%) | | | 0.549 | | Absent | 0 | 3 (4.1) | | Present | 37 (100) | 71 (95.9) | | , (%) | | | 0.241 | | 0 | 29 (78.4) | 52 (70.3) | | 1 | 8 (21.6) | 19 (25.7) | | 2 | 0 | 3 (4.1) | | Child-Pugh, (%) | | | 0.834 | | A | 25 (67.6) | 48 (64.9) | | B | 12 (32.4) | 26 (35.1) | | BCLC, (%) | | | 1.000 | | B | 25 (67.6) | 50 (67.6) | | C | 12 (32.4) | 24 (32.4) | | Tumor number, (%) | | | 1.000 | | ≤3 | 19 (51.4) | 38 (51.4) | | >3 | 18 (48.6) | 36 (48.6) | | Tumor size (cm), (%) | | | 0.690 | | <5 | 20 (54.1) | 43 (58.1) | | ≥5 | 17 (45.9) | 31 (41.9) | | Tumor thrombus, (%) | | | 0.136 | | Absent | 35 (94.6) | 62 (83.8) | | Present | 2 (5.4) | 12 (16.2) | | Lymph node metastasis, (%) | | | 0.427 | | Absent | 29 (78.4) | 63 (85.1) | | Present | 8 (21.6) | 11 (14.9) | | Distant metastasis, (%) | | | 0.748 | | Absent | 34 (91.9) | 65 (87.8) | | Present | 3 (8.1) | 9 (12.2) | | Alpha-fetoprotein (ng/ml), (%) | | | 0.408 | | <400 | 22 (59.5) | 50 (67.6) | | ≥ 400 | 15 (40.5) | 24 (32.4) | | TB, | | | 0.439 | | ALB, | | | 0.043 | | ALT, | | | 0.932 | | AST, | | | 0.856 | | PT, | | | 0.411 | | Ascites, (%) | | | 1.000 | | Absent | 32 (86.5) | 64 (86.5) | | Present | 5 (13.5) | 10 (13.5) |
|
|
